Announced
Synopsis
Novozymes, a provider of biological solutions, agreed to acquire a majority stake in Synergia Life Sciences, a manufacturer of chemicals and chemical products, pharmaceuticals and botanical products, for $150m. "Novozymes’ strong presence in the functional foods and dietary supplement space makes this a strategic fit for Synergia’s innovative product portfolio. We are very excited to be part of the Novozymes family," Dilip Mehta, Synergia Life Sciences CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.